RxDoctor Payments Data

Kimberly Dean, DO

Family Medicine · Largo, FLNPI 1194765214

Payments from drug & device makers

$1,332in general payments, 2019–2025

Across 67 payments — averaging $19.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$379
  • Novo Nordisk$223
  • GSK$119
  • Abbott$117
  • Lilly USA, LLC$116
  • Pfizer$75
  • plus $303 from 9 others

What the payments were for

  • Food & beverage$1,332100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,332 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$41,129
Medicare patients
135
Services billed
789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban103$100,553
FarxigaDapagliflozin Propanediol79$83,676
MounjaroTirzepatide60$64,343
TrulicityDulaglutide22$36,403
OzempicSemaglutide15$33,243
XareltoRivaroxaban38$32,685
JardianceEmpagliflozin25$32,272
Breo ElliptaFluticasone/Vilanterol27$20,581
CreonLipase/Protease/Amylase12$15,749
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,048
BelsomraSuvorexant19$8,093
LantusInsulin Glargine,hum.Rec.Anlog25$5,178
Albuterol Sulfate HfaAlbuterol Sulfate120$4,560
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$3,965
Novolin NInsulin Nph Human Isophane15$3,364

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$116$100,74682 claims
PfizerEliquis$75$100,553103 claims
Novo NordiskOzempic$223$33,24315 claims
Johnson & JohnsonXarelto$71$32,68538 claims
Boehringer IngelheimJardiance$23$32,27225 claims
GSKBreo Ellipta, Trelegy Ellipta$119$31,62844 claims
AbbVieCreon, Synthroid$379$17,71961 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Largo

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →